PFE
Pfizer Inc. · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares -3.8% ·
flujo de acciones -1.1% ·
nuevas posiciones netas -8.0%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 173 | +3 | 3.03B | $72.98B | +7 | −5 |
| Q1 2026 | 174 | -2 | 3.01B | $84.42B | +3 | −6 |
| Q4 2025 | 175 | 0 | 3.18B | $79.18B | +2 | −1 |
| Q3 2025 | 25 | -1 | 1.84B | $46.80B | +1 | −3 |
| Q2 2025 | 24 | -1 | 1.79B | $43.32B | — | −1 |
| Q1 2025 | 22 | +1 | 777.51M | $19.69B | +2 | −1 |
| Q4 2024 | 21 | +2 | 779.18M | $20.66B | +2 | — |
| Q3 2024 | 18 | -2 | 507.62M | $14.68B | — | −2 |
| Q2 2024 | 20 | — | 545.09M | $15.24B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 534.32M | +0.2% | $13.61B | 0.2% | ▲ Add | 2 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (pasivo) | 497.43M | +0.5% | $12.67B | 0.2% | ▲ Add | 2 | SEC ↗ ×23 |
| 3 | State Street Global Advisors ✦ (pasivo) | 299.09M | +0.9% | $7.62B | 0.3% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 129.01M | +1.2% | $3.28B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 74.77M | — | $1.91B | 0.1% | n/c | 1 | SEC ↗ ×18 |
| 6 | Wellington Management ✦ | 60.46M | -21.5% | $1.54B | 0.3% | ▼ Trim | 6 | SEC ↗ ×7 |
| 7 | JPMorgan Chase ✦ | 56.53M | — | $1.44B | 0.0% | n/c | 1 | SEC ↗ ×36 |
| 8 | Fisher Asset Management ✦ | 49.29M | +1.9% | $1.26B | 0.5% | ▲ Add | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 32.82M | — | $836.14M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 10 | Arrowstreet Capital ✦ | 18.57M | -0.8% | $473.05M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 14.40M | -18.9% | $366.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 12 | Capital World Investors ✦ | 14.15M | +2.1% | $360.46M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 12.04M | +7.0% | $306.87M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 10.29M | -30.8% | $262.11M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 9.51M | +120.9% | $230.99M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 16 | Marshall Wace ✦ | 6.98M | +1458.2% | $177.83M | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | D. E. Shaw & Co. ✦ | 5.90M | +57.5% | $150.43M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | Adage Capital Partners ✦ | 3.79M | -23.6% | $96.52M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 3.40M | +465.9% | $86.52M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 1.76M | -87.5% | $44.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 1.47M | +62.8% | $37.51M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 22 | Fairfax Financial ✦ | 890.90K | +36.9% | $22.69M | 1.1% | ▲ Add | 6 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 563.30K | -16.1% | $14.35M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Dodge & Cox ✦ | 93.01K | -13.8% | $2.37M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 75.93K | Nuevo | $1.93M | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Two Sigma Investments | $1.93M | 0.0% |
Posición cerrada
| Norges Bank | $2.27B | era 0.3% |
| Starboard Value | $207.06M | era 3.6% |
| Bridgewater Associates | $24.55M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 225.90K acciones, $6,343 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Officer, Director · Chairman & CEO · 38.00K acc. @ 26.34 · $1.00M
Ventas en mercado abierto (S)
Sin ventas en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología